These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 24243925)
1. Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials. Robson J; Doll H; Suppiah R; Flossmann O; Harper L; Höglund P; Jayne D; Mahr A; Westman K; Luqmani R Ann Rheum Dis; 2015 Jan; 74(1):177-84. PubMed ID: 24243925 [TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials. Robson J; Doll H; Suppiah R; Flossmann O; Harper L; Höglund P; Jayne D; Mahr A; Westman K; Luqmani R Rheumatology (Oxford); 2015 Mar; 54(3):471-81. PubMed ID: 25205825 [TBL] [Abstract][Full Text] [Related]
3. Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials. Suppiah R; Hadden RD; Batra R; Arden NK; Collins MP; Guillevin L; Jayne DR; Luqmani RA; Rheumatology (Oxford); 2011 Dec; 50(12):2214-22. PubMed ID: 21890618 [TBL] [Abstract][Full Text] [Related]
4. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial. Jones RB; Furuta S; Tervaert JW; Hauser T; Luqmani R; Morgan MD; Peh CA; Savage CO; Segelmark M; Tesar V; van Paassen P; Walsh M; Westman K; Jayne DR; Ann Rheum Dis; 2015 Jun; 74(6):1178-82. PubMed ID: 25739829 [TBL] [Abstract][Full Text] [Related]